Latest Content

Physicians recommend a Mediterranean, or similar, diet to slow the progression of age-related macular degeneration (AMD), which is the leading cause of irreversible vision loss in older adults.

Pamela Theriot, OD, FAAO, discussed comprehensive eye exams, managing pediatric dry eye symptoms, and avoiding digital eye strain as back to school season begins.

Host Hamza Shah, OD, MS, FAAO, is joined by Andrew Rixon, OD, FAAO, to discuss OCT and OCTA's utility in identifying neurogeneration, inspired by Lepoittevin et al's paper, "Retinal biomarkers for early Alzheimer's detection: a systematic review of optical coherence tomography (OCT) findings."

Weighing in on The Lancet Diabetes & Endocrinology's expert panel and its division of obesity diagnoses.

Catch up on the top stories in optometry during the week of July 27-31.

PROSE treatment and Mackie stage improvement in neurotrophic keratitis: retrospective study design and primary results.

Maria Sampalis, OD, weighs in on how she has tripled her private practice's growth during her career and how she has used the back to school season as an opportunity to strengthen that growth.

Philip Morgan, BSc, PhD, MCOptom, FAAO, and Lyndon Jones, DSc, PhD, FCOptom, discuss the latest data on contact lens profitability released from the Contact Lens Institute.

Toric, spheric, and multifocal contact lenses are 86%, 79%, and 29% more profitable, respectively, than equivalent glasses-only patients.

The trial will enroll approximately 111 patients across the US and Europe following positive FDA feedback from a Type D meeting

Jade Coats, OD, FAAO, stated that providing pre- and post-op patient care can provide an opportunity to support ophthalmologists.

Through at home delivery, and in-office dispense in permitted states, Orasis Pharmaceuticals and BlinkRx aim to improve accessibility of Qlosi eye drops for presbyopia treatment.

Protecting eye health today requires more than regular eye exams and good lighting